0.80%| Prev Close: | 75.75 |
|---|---|
| Open: | 75.33 |
| Bid: | 77.50 x 200 |
| Ask: | 82.23 x 100 |
| 1y Target Est: | 52.38 |
| Beta: | 1.03 |
| Next Earnings Date: | N/A |
| Day's Range: | 74.72 - 78.37 |
|---|---|
| 52wk Range: | 42.47 - 78.37 |
| Volume: | 1,428,714 |
| Avg Vol (3m): | 1,406,360 |
| Market Cap: | 23.91B |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.43 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 5 Stocks Mega-Fund Osterweis Capital Is Bullish Onat Seeking Alpha(Fri, May 17)
- Final Trade: Your First Move for Monday, May 20at CNBC(Fri, May 17)
- [video] FMHR Final Tradeat CNBC(Fri, May 17)
- Following Up an Acquisition With an Even Larger Merger?at Motley Fool(Thu, May 16)
- Drugmaker Actavis' shares upAP(Thu, May 16)
- Ahead of the Bell: Drugmaker Actavis' shares upAP(Thu, May 16)
- Early Movers: WMT, KSS, CSCO & Moreat CNBC(Thu, May 16)
- Actavis - A Potential Deal With Warner Chilcott Would Further Spur Interest In Actavis Itselfat Seeking Alpha(Thu, May 16)
- VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Wed, May 15)
- Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsCNW Group(Wed, May 15)
- Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsPR Newswire(Wed, May 15)
- Actavis Gaining More From Purchase Than Sale: Real M&Aat Bloomberg(Wed, May 15)
- Why This Stock's Crash is a Buying Opportunityat Motley Fool(Tue, May 14)
- Valeant Pharmaceuticals International Stock Hits New 52-Week High (VRX)at TheStreet(Tue, May 14)
- VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers, FinancialEDGAR Online(Tue, May 14)
Press Releases
- Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsCNW Group(Wed, May 15)
- Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeant's Board of DirectorsPR Newswire(Wed, May 15)
- Valeant Pharmaceuticals To Webcast 2013 Annual Meeting Of ShareholdersCNW Group(Mon, May 13)
Reports
- VRX - Valeant Pharmaceuticals International Inc - Rated a Hold - Company Analysis...Alpha Street Research(May 21)
- Market Edge Equity Research ReportMarket Edge(May 20)
- Trading Report for (VRX). A detailed report, including free correlated market...Stock Traders Daily(May 18)